tiprankstipranks
Omaxe Limited (IN:OMAXE)
:OMAXE
India Market

Omaxe Limited (OMAXE) AI Stock Analysis

0 Followers

Top Page

IN:OMAXE

Omaxe Limited

(OMAXE)

Select Model
Select Model
Select Model
Underperform 39 (OpenAI - 5.2)
Rating:39Underperform
Price Target:
₹75.00
▼(-6.03% Downside)
Action:ReiteratedDate:11/19/25
The overall stock score is heavily influenced by significant financial challenges, including negative equity and profitability issues. Technical analysis further indicates bearish momentum, while valuation metrics reflect ongoing losses. These factors collectively suggest a high-risk investment with limited appeal.
Positive Factors
Business model diversification
Omaxe earns from both project sales and recurring leasing income. This dual revenue mix provides structural diversification: one-time development cashflows from sales plus steadier annuity-like leasing receipts, which can smooth revenue volatility and support operations across real estate cycles.
Negative Factors
Negative equity / high leverage
Negative shareholders' equity signals capital impairment and elevated solvency risk; it constrains access to traditional financing, may trigger covenant breaches, and increases reliance on asset sales or restructurings. This structural weakness limits strategic flexibility for months ahead.
Read all positive and negative factors
Positive Factors
Negative Factors
Business model diversification
Omaxe earns from both project sales and recurring leasing income. This dual revenue mix provides structural diversification: one-time development cashflows from sales plus steadier annuity-like leasing receipts, which can smooth revenue volatility and support operations across real estate cycles.
Read all positive factors

Omaxe Limited (OMAXE) vs. iShares MSCI India ETF (INDA)

Omaxe Limited Business Overview & Revenue Model

Company Description
Omaxe Limited engages in the real estate development activities in India. It develops and sells integrated and hi-tech townships, group housing projects, shopping malls, office spaces, SCOs, and hotels. The company was formerly known as Omaxe Cons...
How the Company Makes Money
Omaxe Limited primarily generates revenue through the sale of residential and commercial properties. The company develops large-scale real estate projects, which are sold to individual buyers and corporate clients. Additionally, Omaxe earns income...

Omaxe Limited Financial Statement Overview

Summary
Omaxe Limited is experiencing financial strain, characterized by ongoing losses and high leverage. The negative equity and profitability challenges indicate significant financial risks, despite some operational support from cash flows.
Income Statement
25
Negative
Balance Sheet
20
Very Negative
Cash Flow
40
Negative
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue14.59B15.61B16.14B7.73B6.18B4.76B
Gross Profit-4.05B-4.50B-1.75B-929.60M601.70M21.90M
EBITDA-5.07B-5.32B-3.48B-2.87B-447.00M-996.90M
Net Income-6.51B-6.86B-4.03B-3.48B-1.60B-2.35B
Balance Sheet
Total Assets157.28B148.77B138.22B135.60B119.18B110.42B
Cash, Cash Equivalents and Short-Term Investments9.77B7.44B5.40B4.93B1.28B2.75B
Total Debt14.19B7.96B6.79B11.07B11.28B15.30B
Total Liabilities162.76B150.74B133.33B126.50B106.58B96.20B
Stockholders Equity-5.57B-2.05B4.80B8.98B12.45B14.05B
Cash Flow
Free Cash Flow-664.20M3.28B9.70B4.49B7.66B5.58B
Operating Cash Flow-568.70M3.52B9.87B4.69B7.83B5.66B
Investing Cash Flow1.02B-1.55B-640.20M-1.42B-221.50M227.20M
Financing Cash Flow2.84B-863.50M-9.24B-2.62B-7.40B-5.17B

Omaxe Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price79.81
Price Trends
50DMA
75.14
Positive
100DMA
74.06
Positive
200DMA
82.64
Negative
Market Momentum
MACD
-0.94
Negative
RSI
55.57
Neutral
STOCH
78.91
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:OMAXE, the sentiment is Positive. The current price of 79.81 is above the 20-day moving average (MA) of 71.31, above the 50-day MA of 75.14, and below the 200-day MA of 82.64, indicating a neutral trend. The MACD of -0.94 indicates Negative momentum. The RSI at 55.57 is Neutral, neither overbought nor oversold. The STOCH value of 78.91 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:OMAXE.

Omaxe Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
₹3.08B42.0349.74%-26.42%
65
Neutral
$2.17B12.193.79%4.94%3.15%1.96%
58
Neutral
₹28.31B39.3364.29%
54
Neutral
₹13.10B-52.7213.78%63.01%
51
Neutral
₹9.95B72.560.48%16.36%28.21%
40
Underperform
₹2.92B-0.76-37.98%40.32%
39
Underperform
₹13.85B-2.47-22.30%-8.72%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:OMAXE
Omaxe Limited
75.74
1.43
1.92%
IN:ARIHANTSUP
Arihant Superstructures Limited
230.00
-155.20
-40.29%
IN:ATALREAL
Atal Realtech Limited
24.87
9.12
57.90%
IN:HUBTOWN
Hubtown Limited
199.20
0.25
0.13%
IN:PARSVNATH
Parsvnath Developers Limited
6.72
-17.35
-72.08%
IN:SHRIRAMPPS
Shriram Properties Ltd.
76.77
7.06
10.13%

Omaxe Limited Corporate Events

Omaxe Unveils India’s First ‘Pink Stand’ Honouring Harmanpreet Kaur at Dwarka Stadium
Mar 25, 2026
Omaxe has unveiled India’s first dedicated ‘Pink Stand’ at The Omaxe State Stadium in Dwarka, naming the 1,500-plus seat section in the North Pavilion after Indian women’s cricket captain Harmanpreet Kaur. The stand forms p...
Omaxe to Invest Rs 500 Crore in Mixed-Use Omaxe Chowk Project in Ludhiana
Jan 13, 2026
Omaxe Limited has announced a Rs. 500 crore investment in a new mixed-use development, Omaxe Chowk in Ludhiana, positioned as a high-street retail and luxury residential hub on a 5.25-acre leasehold parcel in the prime Ghumar Mandi area. Designed ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 19, 2025